The IBMS welcomes the publication of the COVID-19 Inquiry’s Module 2 report which examines core decision-making, political governance and public health responses during the pandemic.
The Institute of Biomedical Science (IBMS), the Royal College of Pathologists (RCPath) and the Association for Laboratory Medicine (LabMed) have released a joint statement announcing a temporary pause in national quality assurance panel activities while a sustainable model is developed.
Developed by IBMS with Roche Diagnostics UK, with support from RCPath and LabMed, the report provides actionable guidance to improve standards, workforce capability and patient outcomes.
